<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03324490</url>
  </required_header>
  <id_info>
    <org_study_id>TSEANORLDP60</org_study_id>
    <nct_id>NCT03324490</nct_id>
  </id_info>
  <brief_title>Thoracic Spinal Versus Epidural Anesthesia for Nephrectomy in Obstructive/Restrictive Lung Disease Patients</brief_title>
  <official_title>Comparative Study of Mid-thoracic Spinal Versus Epidural Anesthesia for Open Nephrectomy in Patients With Obstructive/Restrictive Lung Disease: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nazmy Edward Seif</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with respiratory disease have an increased risk of developing complications
      perioperatively. The use of regional anesthesia decreases this risk with better postoperative
      outcome. The aim of this study is to compare the safety and efficacy of thoracic spinal
      versus thoracic epidural anesthesia for open nephrectomy in patients with
      obstructive/restrictive lung disease.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 1, 2017</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Using computer &amp; sealed envelope randomization, patients are assigned to receive either thoracic spinal anesthesia [TSA group: n=30] or thoracic epidural anesthesia [TEA group: n=30].</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS</measure>
    <time_frame>24 hours</time_frame>
    <description>Visual Analogue Score for pain graded from 0-10 [0: no pain, 10: worst pain]</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Nephrectomy</condition>
  <condition>Lung Diseases</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>TSA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic Spinal Anesthesia; Bupivacaine 0.5% (hyperbaric) 7.5mg, Fentanyl 25 µg &amp; Dexmedetomidine 5 µg by intrathecal injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thoracic Epidural Anesthesia; Bupivacaine 0.5% (isobaric) 25-50 mg &amp; Fentanyl 10-20 µg by epidural injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic Spinal Anesthesia</intervention_name>
    <description>Spinal anesthesia will be performed for patients of the TSA group at the T7-T8 intervertebral space, using a 27 G pencil point needle with an introducer (Braun Melsungen, Melsungen, Germany).
When correct placement is confirmed by the free flow of clear CSF, 1.5 ml of hyperbaric Bupivacaine 0.5% (7.5 mg) in addition to 0.5 ml Fentanyl (25 μg) &amp; 5 μg dexmedetomidine will be injected.</description>
    <arm_group_label>TSA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracic Epidural Anesthesia</intervention_name>
    <description>Epidural anesthesia will be performed for patients of the TEA group at the T7-T8 intervertebral space, using the &quot;Prefix Custom Epidural Anesthesia Tray&quot; with an 18 G Tuohy epidural needle &amp; a 20 G epidural catheter.
Patients will initially receive 5-10 ml of a mixed preparation of 0.5% isobaric Bupivacaine with 2 μg Fentanyl per ml volume as a bolus dose via the epidural catheter, this will be followed by a continuous infusion of 5-10 ml/hr started 1 hour after the bolus dose &amp; continued throughout the procedure.</description>
    <arm_group_label>TEA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.5% (hyperbaric)</intervention_name>
    <description>Neuro-axially injected</description>
    <arm_group_label>TSA group</arm_group_label>
    <other_name>Heavy Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine 0.5% (isobaric)</intervention_name>
    <description>Neuro-axially injected</description>
    <arm_group_label>TEA group</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Neuro-axially injected</description>
    <arm_group_label>TSA group</arm_group_label>
    <arm_group_label>TEA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Neuro-axially injected</description>
    <arm_group_label>TSA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA class II or III

          -  Mild to moderate obstructive or restrictive lung disease

          -  Open nephrectomy candidate patients

        Exclusion Criteria:

          -  Any condition contra-indicating regional anesthesia

          -  Allergic to any of the drugs used during the procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nazmy E Seif, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Kasr Al-Ainy Hospital, Cairo University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ahmed M El-Badawy, MD</last_name>
    <role>Study Director</role>
    <affiliation>Kasr Al-Ainy Hospital, Cairo University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kasr Al-Ainy Hospital, Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2017</study_first_submitted>
  <study_first_submitted_qc>October 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2017</study_first_posted>
  <last_update_submitted>May 7, 2018</last_update_submitted>
  <last_update_submitted_qc>May 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nazmy Edward Seif</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Mid-thoracic spinal anesthesia</keyword>
  <keyword>Mid-thoracic epidural anesthesia</keyword>
  <keyword>Nephrectomy</keyword>
  <keyword>Lung disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

